Results 121 to 130 of about 18,017 (247)
, 2018 Background Although factor Xa inhibitors have become a popular choice for chronic oral anticoagulation, effective drug reversal remains difficult due to a lack of specific antidote.
Elena N. Bukanova +2 more
core +1 more source
Clinical Case Reports, Volume 14, Issue 6, June 2026.ABSTRACT Post‐dengue cerebral venous sinus thrombosis is an uncommon complication of dengue fever. It occurs due to a prothrombotic shift during the recovery or critical phase of dengue fever, presenting usually as a persistent headache. Prompt neuroimaging and anticoagulation are crucial to a favorable prognosis, even in the presence of hemorrhagic ...
Zain Ul Abedeen +5 more
wiley +1 more source
The Canadian Journal of Chemical Engineering, Volume 104, Issue 6, Page 2842-2861, June 2026.Abstract The waste activated sludge high‐rate (WASHR) process, developed in our previous study, is used for septic wastewater treatment. This high‐rate contact stabilization pre‐treatment uses typical waste streams found in wastewater treatment plants to reduce a portion of the loadings on the main treatment trains.
Arman Shirali +2 more
wiley +1 more source
, 2014 Factor-Xa inhibitors are often used for prophylaxis and for the treatment of thrombotic vascular disorders. However, it is not known whether they are beneficial during the recanalization of the thrombotic vascular segment and during tissue reperfusion ...
Guclu, Orkut +6 more
core +1 more source
eFood, Volume 7, Issue 3, June 2026.ABSTRACT Raspberry (Rubus idaeus L.) leaves are an abundant agri‐food by‐product with high potential as a source of natural bioactive compounds. In this study, ultrasound‐assisted extraction (UAE) was applied as a green approach to recover phenolic‐rich extracts, which were subsequently characterized by HPLC–DAD and high‐resolution mass spectrometry ...
Sara Bolchini +6 more
wiley +1 more source
Reversing anti–factor Xa agents and the unmet needs in trauma patients
, 2018 Andexanet alfa, a reversing agent for anticoagulants that inhibit factor Xa, has recently been licensed in the United States. We discuss the impact of this licensure on current practice and review in detail the problems of a neglected and growing ...
Neal, Matthew D. +2 more
core +1 more source
Nutritional, phytochemical, and potential health benefits of Monostroma spp.: A systematic review
Food Biomacromolecules, Volume 3, Issue 2, Page 252-272, June 2026.Abstract Monostroma spp., belonging to the green seaweed, has been known to be health‐promoting food items as prophylactic agents worldwide. It has shown wide arrays of bioactivities for the prevention and treatment of various diseases. A total of 47 articles were selected to review following the Preferred Reporting Items for Systematic reviews and ...
Md Shariful Islam
wiley +1 more source
Andexanet alfa for the reversal of Factor Xa inhibitor related anticoagulation
, 2016 Andexanet alfa is a specific reversal agent for Factor Xa inhibitors. The molecule is a recombinant protein analog of factor Xa that binds to Factor Xa inhibitors and antithrombin:LMWH complex but does not trigger prothrombotic activity.
Dombrowski, KE +3 more
core +1 more source
Optimization of 4-amidinobenzylamide-derived inhibitors of coagulation factor Xa
, 2011 Die Entwicklung von wirksamen und sicheren Antikoagulantien, die ergänzend und anstelle der bisherigen Standardtherapeutika zur Behandlung thromboembolischer Erkrankungen eingesetzt werden können, ist weltweit ein aktuelles Forschungsziel vieler Firmen ...
Stürzebecher, Anne
core +1 more source
eJHaem, Volume 7, Issue 3, June 2026.ABSTRACT Background Multiple myeloma (MM) carries a high venous thromboembolism (VTE) risk; aspirin shows limited efficacy, while factor‐Xa inhibitors show promise. Objectives Evaluate apixaban for primary thromboprophylaxis in newly diagnosed MM (NDMM).
K. Alexandra Sanchez +5 more
wiley +1 more source